BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 425120)

  • 41. Platelet monoamine oxidase and blood plasma benzylamine oxidase activity in cirrhotic patients.
    Cortesini C; Buffoni F; Ignesti G; Pirisino R; Sestini MC
    Boll Soc Ital Biol Sper; 1982 Aug; 58(15):982-6. PubMed ID: 7126373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disposition of 14C-mescaline by rabbit lung.
    Roth RA; Roth JA; Gillis CN
    J Pharmacol Exp Ther; 1977 Feb; 200(2):394-401. PubMed ID: 839444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of dosage-dependent effects of beta-aminopropionitrile, sodium fluoride, and hydrocortisone on selected physical properties of cortical bone.
    Lees S; Hanson D; Page E; Mook HA
    J Bone Miner Res; 1994 Sep; 9(9):1377-89. PubMed ID: 7817821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The order of substrate addition and product release during the catalytic action of pig-plasma benzylamine oxidase.
    Lindström A; Pettersson G
    Eur J Biochem; 1978 Mar; 84(2):479-85. PubMed ID: 25180
    [No Abstract]   [Full Text] [Related]  

  • 45. The effect of pargyline on the metabolism of ethanol and acetaldehyde by isolated rat liver cells.
    Cederbaum AI; Dicker E
    Arch Biochem Biophys; 1979 Apr; 193(2):551-9. PubMed ID: 464611
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of the effects of semicarbazide and beta-aminopropionitrile on the arterial extracellular matrix in the Brown Norway rat.
    Mercier N; Kakou A; Challande P; Lacolley P; Osborne-Pellegrin M
    Toxicol Appl Pharmacol; 2009 Sep; 239(3):258-67. PubMed ID: 19524603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Preliminary tests of the action of an MAO inhibitor (Pargyline) on iris motility].
    Balacco-Gabrieli C
    Boll Soc Ital Biol Sper; 1971 Jan; 47(2):33-5. PubMed ID: 5088815
    [No Abstract]   [Full Text] [Related]  

  • 48. Beta-aminopropionitrile as a radiation reaction preventive agent.
    Percarpio B; Fischer JJ
    Radiology; 1976 Dec; 121(3 Pt. 1):737-40. PubMed ID: 981676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phenytoin inhibition: failure to inhibit periosteal responses to lathyrogen.
    Fallon MD; Yeager VL; Taylor JL
    Arch Pathol Lab Med; 1977 Feb; 101(2):102-5. PubMed ID: 576390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potentiating effect of beta-aminopropionitrile on the DNA synthesis induced by isoproterenol.
    Sasaki T; Yamamoto M
    Cancer Res; 1979 Jul; 39(7 Pt 1):2751-4. PubMed ID: 445478
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of pargyline and other monoamine oxidase inhibitors on blood acetaldehyde levels in ethanol-intoxicated mice.
    Dembiec D; MacNamee D; Cohen G
    J Pharmacol Exp Ther; 1976 May; 197(2):332-9. PubMed ID: 944772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Allylamine cardiotoxicity--IV. Metabolism to acrolein by cardiovascular tissues.
    Nelson TJ; Boor PJ
    Biochem Pharmacol; 1982 Feb; 31(4):509-14. PubMed ID: 7066019
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Changes in the catalytic properties of benzylamine oxidase.
    Silva IJ; Azevedo MS; Manso CF
    Biochem Soc Trans; 1995 May; 23(2):234S. PubMed ID: 7672255
    [No Abstract]   [Full Text] [Related]  

  • 54. The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline.
    Fowler CJ; Mantle TJ; Tipton KF
    Biochem Pharmacol; 1982 Nov; 31(22):3555-61. PubMed ID: 6817759
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The binding of [3H] pargyline to rat liver mitochondrial monoamine oxidase.
    Parkinson D; Callingham BA
    J Pharm Pharmacol; 1980 Jan; 32(1):49-54. PubMed ID: 6102127
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects on enzyme activity of ligand-binding to copper in pig-plasma benzylamine oxidase.
    Olsson B; Olsson J; Pettersson G
    Eur J Biochem; 1978 Jun; 87(1):1-8. PubMed ID: 27352
    [No Abstract]   [Full Text] [Related]  

  • 57. The B-aminopropionitrile-fed turkey: a model for detecting potential drug action on arterial tissue.
    Simpson CF; Boucek RJ
    Cardiovasc Res; 1983 Jan; 17(1):26-32. PubMed ID: 6850714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of hydralazine on aortic rupture induced by B-aminopropionitrile in turkeys.
    Simpson CF; Taylor WJ
    Circulation; 1982 Apr; 65(4):704-8. PubMed ID: 7060248
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Highly reproducible skeletal deformities induced by administration of β-aminopropionitrile to developing chick embryos.
    Kubota S; Yuguchi M; Yamazaki Y; Kanazawa H; Isokawa K
    J Oral Sci; 2016; 58(2):255-63. PubMed ID: 27349548
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preferential inhibition of the low Km aldehyde dehydrogenase activity by pargyline.
    Lebsack ME; Petersen DR; Collins AC; Anderson AD
    Biochem Pharmacol; 1977 Jun; 26(12):1151-4. PubMed ID: 560851
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.